At a glance

ClinicalIndex Comparison Record

N/ACompleted· 798 enrolled

Drug / intervention

Genetic +1 moregenetic

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01355224

NCT01355224N/ACompleted

Compare CT.gov

Communicating Genetic Information for Obesity

Boston University·interventional·Posted May 18, 2011·Updated Mar 14, 2017

In Brief

A clinical study evaluating Genetic and Lifestyle for Obesity. Completed, enrolled 798 participants across 1 site.

Detailed Summary

This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized Medicine Collaborative (CPMC), see below for description of CPMC.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsObesity

CountriesUnited States

CollaboratorsNational Human Genome Research Institute (NHGRI)

Timeline

N/ACompletedFinished

2011201220132014201520162017201820192020202120222023202420252026

First PostedMay 2011

Enrollment StartSep 2011

Primary CompletionSep 2013

TodayJul 2026

First PostedMay 18, 2011

Enrollment StartSep 1, 2011

Primary CompletionSep 1, 2013

TodayJul 2, 2026

Enrollment to primary: 2 yearsPosted 15.1 years ago

Interventions

Geneticgenetic

Relative risk estimates will be presented based on individuals' risk for obesity based on FTO genotype results.

Lifestylebehavioral

Relative risk estimates will be presented based on individuals' risk for obesity due to lifestyle factors.